Omnicell, Inc. (OMCL): Price and Financial Metrics


Omnicell, Inc. (OMCL): $157.94

0.13 (+0.08%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

OMCL POWR Grades


  • OMCL scores best on the Growth dimension, with a Growth rank ahead of 99.52% of US stocks.
  • The strongest trend for OMCL is in Growth, which has been heading up over the past 51 weeks.
  • OMCL ranks lowest in Momentum; there it ranks in the 38th percentile.

OMCL Stock Summary

  • With a one year PEG ratio of 221.94, OMNICELL Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 87.65% of US stocks.
  • With a price/earnings ratio of 114.86, OMNICELL Inc P/E ratio is greater than that of about 93.05% of stocks in our set with positive earnings.
  • With a year-over-year growth in debt of 1,013.87%, OMNICELL Inc's debt growth rate surpasses 98.46% of about US stocks.
  • Stocks that are quantitatively similar to OMCL, based on their financial statements, market capitalization, and price volatility, are SLP, TECH, RGEN, ECOM, and VSAT.
  • Visit OMCL's SEC page to see the company's official filings. To visit the company's web site, go to www.omnicell.com.

OMCL Valuation Summary

  • In comparison to the median Technology stock, OMCL's price/sales ratio is 30.19% higher, now standing at 6.9.
  • Over the past 243 months, OMCL's price/earnings ratio has gone up 131.6.
  • Over the past 243 months, OMCL's EV/EBIT ratio has gone up 105.1.

Below are key valuation metrics over time for OMCL.

Stock Date P/S P/B P/E EV/EBIT
OMCL 2021-09-01 6.9 6.5 114.9 85.8
OMCL 2021-08-31 6.8 6.4 113.0 84.4
OMCL 2021-08-30 6.9 6.4 113.3 84.6
OMCL 2021-08-27 7.0 6.6 115.5 86.3
OMCL 2021-08-26 6.8 6.4 112.5 84.0
OMCL 2021-08-25 6.9 6.4 113.6 84.8

OMCL Growth Metrics

  • Its year over year net cashflow from operations growth rate is now at 51.7%.
  • Its 2 year revenue growth rate is now at 23.52%.
  • Its 4 year net cashflow from operations growth rate is now at 224.95%.
OMCL's revenue has moved up $213,980,000 over the prior 33 months.

The table below shows OMCL's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 987.483 242.323 59.733
2021-03-31 914.365 218.054 35.01
2020-12-31 892.208 185.87 32.194
2020-09-30 891.298 144.242 37.912
2020-06-30 906.404 163.983 49.09
2020-03-31 924.196 143.742 69.365

OMCL's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • OMCL has a Quality Grade of C, ranking ahead of 59.08% of graded US stocks.
  • OMCL's asset turnover comes in at 0.534 -- ranking 55th of 83 Computers stocks.
  • STRM, PBI, and SLP are the stocks whose asset turnover ratios are most correlated with OMCL.

The table below shows OMCL's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.534 0.485 0.087
2021-03-31 0.550 0.466 0.054
2020-12-31 0.595 0.463 0.052
2020-09-30 0.658 0.464 0.064
2020-06-30 0.734 0.473 0.105
2020-03-31 0.752 0.486 0.148

OMCL Price Target

For more insight on analysts targets of OMCL, see our OMCL price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $167.50 Average Broker Recommendation 1.55 (Moderate Buy)

OMCL Stock Price Chart Interactive Chart >

Price chart for OMCL

OMCL Price/Volume Stats

Current price $157.94 52-week high $163.78
Prev. close $157.81 52-week low $78.13
Day low $157.70 Volume 188,500
Day high $160.66 Avg. volume 303,796
50-day MA $155.74 Dividend yield N/A
200-day MA $141.28 Market Cap 6.87B

Omnicell, Inc. (OMCL) Company Bio


Omnicell provides automation and business analytics software for patient-centric medication and supply management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. The company was founded in 1992 and is based in Mountain View, California.


OMCL Latest News Stream


Event/Time News Detail
Loading, please wait...

OMCL Latest Social Stream


Loading social stream, please wait...

View Full OMCL Social Stream

Latest OMCL News From Around the Web

Below are the latest news stories about OMNICELL Inc that investors may wish to consider to help them evaluate OMCL as an investment opportunity.

3 Mid-Cap Stocks With Large-Cap Potential

Large-cap stocks hog the spotlight, but mid-cap stocks have higher growth potential and can help diversify your portfolio.

David Cohne on InvestorPlace | October 15, 2021

CNVY vs. OMCL: Which Stock Should Value Investors Buy Now?

CNVY vs. OMCL: Which Stock Is the Better Value Option?

Yahoo | October 14, 2021

Omnicell to Release Third Quarter 2021 Financial Results on November 2, 2021

MOUNTAIN VIEW, Calif., October 11, 2021--Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the third quarter of 2021 before the open of the market on Tuesday, November 2, 2021. The Company will host a conference call and webcast to discuss its financial results at 8:30 a.m. ET that same day.

Yahoo | October 11, 2021

Zacks Industry Outlook Highlights: 10x Genomics, Omnicell, Inspire Medical Systems and Cerner

Zacks Industry Outlook Highlights: 10x Genomics, Omnicell, Inspire Medical Systems and Cerner

Yahoo | October 8, 2021

FDS Amplicare Hosts Webinar to Advise Pharmacists on Assisting Customers During Medicare Open Enrollment

FDS Amplicare, which builds industry-leading SaaS technology solutions that strengthen the health of retail pharmacies and their patients, today announced that it will host a webinar to help pharmacists learn how to assist patients in selecting the right Prescription Drug, Medicare Advantage and Medigap plans that support their healthcare and financial needs.

Yahoo | October 6, 2021

Read More 'OMCL' Stories Here

OMCL Price Returns

1-mo -1.64%
3-mo 5.02%
6-mo 15.77%
1-year 91.51%
3-year 144.41%
5-year 343.03%
YTD 31.59%
2020 46.87%
2019 33.44%
2018 26.27%
2017 43.07%
2016 9.07%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7768 seconds.